Welcome to Library
Annual Reports
RMRIMS News Bulletine
 
Publications List of Dr. Sanjive Bimal

 

87

Amit A, Vijayamahantesh, Dikhit MR, Singh AK, Kumar V, Suman SS, Singh A, Kumar A, Thakur AK, Das VR, Das P and Bimal S. Immunization with Leishmania donovani protein disulfide isomerase DNA construct induces Th1 and Th17 dependent immune response and protection against experimental visceral leishmaniasis in Balb/c mice. Mol Immunol. 2017 Feb;82:104-113. doi: 10.1016/j.molimm.2016.12.022. Epub 2017 Jan 5.

86

Vijayamahantesh, Amit A, Dikhit MR, Mishra A, Singh AK, Das VN, Das P and Bimal S. Adenosine generated by ectonucleotidases modulates the host immune system during visceral leishmaniasis. Cytokine. 2017 Mar;91:170-179. doi: 10.1016/j.cyto.2017.01.001. Epub 2017 Jan 9.

85

Vijayamahantesh, Amit A, Dikhit MR, Singh AK, Venkateshwaran T, Das VNR, Das P and Bimal S. Immuno-informatics based approaches to identify CD8+ T cell epitopes within the Leishmania donovani 3-ectonucleotidase in cured visceral leishmaniasis subjects. Microbes Infect. 2017 Jun;19(6):358-369. doi: 10.1016/j.micinf.2017.03.002. Epub 2017 Apr 1.

 84

Dikhit MR, Amit A, Singh AK, Kumar A, Mansuri R, Sinha S, Topno RK, Mishra R, Das VNR, Pandey K, Sahoo GC, Ali V, Bimal S and Das P. Vaccine potential of HLA-A2 epitopes from Leishmania Cysteine Protease Type III (CPC). Parasite Immunol. 2017 Sep;39(9). doi: 10.1111/pim.12451. Epub 2017 Jul 28.

83

Shivam P, Kumari S, Jamal F, Kumar V, Kumar M, Bimal S, Narayan S, Das VNR, Pandey K, Gupta AK, Das P and Singh SK. Leishmania donovani resistant to Ambisome or Miltefosine exacerbates CD58 expression on NK cells and promotes trans-membrane migration in association with CD2. Cytokine. 2017; 96:54-58. doi: 10.1016/j.cyto.2017.02.005. Epub 2017 Mar 16.

82

Pandey K, Pal B, Das VN, Murti K, Lal CS, Verma N, Bimal S, Ali V, Verma RB, Topno RK, Siddiqi NA and Das P. Safety and efficacy of a combination of Paromomycin and Miltefosine for two versus three courses in patients with Post Kala-Azar Dermal Leishmaniasis (PKDL) - an observational pilot Study. Br J Dermatol. 2017; 177(2):557-559. doi: 10.1111/bjd.15119. Epub 2017 Jul 2.

81

Kumari A, Singh KP, Mandal A, Paswan RK, Sinha P, Das P, Ali V, Bimal S and Lal CS. Intracellular zinc flux causes reactive oxygen species mediated mitochondrial dysfunction leading to cell death in Leishmania donovani. PLoS One. 2017 Jun 6;12(6):e0178800. doi: 10.1371/journal.pone.0178800. eCollection 2017.

80

Jamal F, Shivam P, Kumari S, Singh MK, Sardar AH, Pushpanjali, Murugesan S, Narayan S, Gupta AK, Pandey K, Das VNR, Ali V, Bimal S, Das P and Singh SK. Identification of Leishmania donovani antigen in circulating immune complexes of visceral leishmaniasis subjects for diagnosis. PLoS One. 2017 Aug 18;12(8):e0182474. doi: 10.1371/journal.pone.0182474. eCollection 2017.

79

Kumari A, Singh KP, Mandal A, Paswan RK, Sinha P, Das P, Ali V, Bimal S and Lal CS. Intracellular zinc flux causes reactive oxygen species mediated mitochondrial dysfunction leading to cell death in Leishmania donovani. PLoS One. 2017; 12(6): e0178800. doi: 10.1371/journal.pone.0178800. eCollection 2017.

78

Amit A, Dikhit MR, Mahantesh V, Chaudhary R, Singh AK, Singh A, Singh SK, Das VN, Pandey K, Ali V, Narayan S, Sahoo GC, Das P and Bimal S. Immunomodulation mediated through Leishmania donovani protein disulfide isomerase by eliciting CD8+ T-cell in cured visceral leishmaniasis subjects and identification of its possible HLA class-1 restricted T-cell epitopes. J Biomol Struct Dyn. 2017; 35(1): 128-140. doi: 10.1080/07391102.2015.1134349.  (Epub 2016 Apr 12)

77

Paswan RK, Bimal S, Kumari A, Sinha P, Das VN, Pandey K, Kumar S, Verma RB, Das P and Lal CS. Reduced High Density Lipoprotein Concentration Modulates Increased Interleukin-10 and Decreased Interferon-Gamma in Visceral Leishmaniasis Patients. Gen Med (Los Angel) 2016; 4:233. doi:10.4172/2327-5146.1000233.

 

76

Jamal F, Dikhit MR, Singh MK, Shivam P, Kumari S, Pushpanjali, Dubey AK, Kumar P, Narayan S, Gupta AK, Pandey K, Das VN, Bimal S, Das P and Singh SK. Identification of B-Cell Epitope of Leishmania donovani and its application in Diagnosis of visceral leishmaniasis. J Biomol Struct Dyn. 2016 Nov 28:1-39. [Epub ahead of print]

75

Sinha P, Paswan RK, Kumari A, Kumar S, Bimal S, Das P and Lal CS. Magnesium-Dependent Ecto-ATP Diphosphohydrolase Activity in Leishmania donovani. Curr Microbiol. 2016; 73(6): 811-819.

74

Dikhit MR, Ansari MY, Vijaymahantesh, Kalyani, Mansuri R, Sahoo BR, Dehury B, Amit A, Topno RK, Sahoo GC, Ali V, Bimal S and Das P. Computational prediction and analysis of potential antigenic CTL epitopes in Zika virus: A first step towards vaccine development. Infect Genet Evol. 2016; 45: 187-197. doi: 10.1016/j.meegid.2016.08.037.

73

Vijayamahantesh, Amit A, Dikhit MR, Pandey RK, Singh K, Mishra R, Das VN, Das P and Bimal S. Elevated Serum ADA Activity as a Marker for Diagnosis and Prognosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis in Indian Patients. PLoS One. 2016; 11(5): e0154117. doi: 10.1371/journal.pone.0154117.

72

Pushpanjali, Thakur AK, Purkait B, Jamal F, Singh MK, Ahmed G, Bimal S, Kumar V, Singh SK, Keshri S, Das P, Narayan S. Direct evidence for role of anti-saliva antibodies against salivary gland homogenate of P. argentipes in modulation of protective Th1-immune response against Leishmania donovani. Cytokine. 2016; 86: 79-85. doi: 10.1016/j.cyto.2016.07.017. (Epub 2016 Jul 30).

71.

Suman SS, Equbal A, Zaidi A, Ansari MY, Singh KP, Singh K, Purkait B, Sahoo GC, Bimal S, Das P and Ali V. Up-regulation of cytosolic tryparedoxin in Amp B resistant isolates of Leishmania donovani and its interaction with cytosolic tryparedoxin peroxidase. Biochimie. 2016; 121: 312-325. doi: 10.1016/j.biochi.2015.12.017. (Epub 2015 Dec 30). 

70.

Vijayamahantesh, Amit A, Kumar S, Dikhit MR, Jha PK, Singh AK, Sinha KK, Pandey K, Das VN, Das P and Bimal S. Up regulation of A2B adenosine receptor on monocytes are crucially required for immune pathogenicity in Indian patients exposed to Leishmania donovani. Cytokine. 2016; 79: 38-44. doi: 10.1016/j.cyto.2015.12.016. (Epub 2015 Dec 31).

69.

Zaidi A, Singh KP, Anwar S, Suman SS, Equbal A, Singh K, Dikhit MR, Bimal S, Pandey K, Das P and Ali V. Interaction of frataxin, an iron binding protein, with IscU of Fe-S clusters biogenesis pathway and its upregulation in AmpB resistant Leishmania donovani. Biochimie. 2015; 115: 120-135. doi: 10.1016/j.biochi.2015.05.016. (Epub 2015 May 30).

68.

Dikhit MR, Kumar S, Vijaymahantesh, Sahoo BR, Mansuri R, Amit A, Ansari MY, Sahoo GC, Bimal S and Das P. Computational elucidation of potential antigenic CTL epitopes in Ebola virus. Infecttion, Genetics and Evolution. 2015; 36: 369-375.

67.

Verma N, Bimal S, Das VNR, Pandey K, Singh D, Lal CS, Singh AS, Sinha PK and Das P. Clinicopathological and Immunological Changes in Indian Post Kala-Azar Dermal Leishmaniasis (PKDL) Cases in relation to Treatment: A Retrospective Study. BioMed Research International 2015; Article ID 745062. http://dx.doi.org/10.1155/2015/745062

66.

Thakur AK, Pushpanjali, Narayan S, Bimal S, Singh SK, Gupta AK and Das P. An approach to hemoglobin recycling through Leishmania infected macrophage and its impact on visceral leishmaniasis. International Journal of Advanced Research 2015; 3(2): 868-877.

65.

Kumari S, Jamal F, Shivam P, Thakur A, Kumar M, Bimal S, Das VN, Pandey K, Narayan S, Gupta AK, Das P and Singh SK. Leishmania donovani skews the CD56(+) Natural Killer T cell response during human visceral leishmaniasis. Cytokine. 2015; 73(1): 53-60. doi: 10.1016/j.cyto.2015.01.011. (Epub 2015 Feb 16).

64.

Yadav A, Amit A, Chaudhary R, Chandel AS, Mahantesh V, Suman SS, Singh SK, Dikhit MR, Ali V, Rabidas V, Pandey K, Kumar A, Das P and Bimal S. Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis. Int J Parasitol. 2015; 45(1): 33-42. doi: 10.1016/j.ijpara.2014.08.013. (Epub 2014 Oct 15).

63.

Das P, Amit A, Singh SK, Chaudhary R, Dikhit MR, Yadav A, Pandey K, Das VN, Sundram S, Das P and Bimal S. Leishmania donovani phosphoproteins pp41 and pp29 re-establishes host protective immune response in visceral leishmaniasis. Parasitol Int. 2015; 64(1): 18-25. doi: 10.1016/j.parint.2014.08.004. (Epub 2014 Sep 16).

62.

Pandey K, Singh D, Bimal S, Murti K and Das P. Association of testosterone and cholesterol level in modulation of immunity and severity of disease in visceral leishmaniasis patients – a preliminary study. American Journal of Immunology, 2014; 10(1): 46-55.

61.

Pandey K, Singh D, Bimal S, Rabidas V, Murti K, Lal CS and Das P. Newer drugs for Visceral Leishmaniasis: a review. American Journal of Infectious Diseases, 2014; 10 (2): 68-70.

60.

Pratap Singh K, Zaidi A, Anwar S, Bimal S, Das P and Ali V. Reactive oxygen species regulates expression of iron-sulfur cluster assembly protein IscS of Leishmania donovani. Free Radic Biol Med. 2014; 75C: 195-209

59.

Amit A, Chaudhary R, Yadav A, Suman SS, Narayan S, Das VN, Pandey K, Singh SK, Singh BK, Ali V, Das P and Bimal S. Evaluation of Leishmania donovani disulfide isomerase as a potential target of cellular immunity against visceral leishmaniasis. Cell Immunol. 2014; 289(1-2): 76-85. doi: 10.1016/j.cellimm.2014.03.011.

58.

Chaudhary R, Amit A, Yadav A, Singh A, Kumar V, Singh SK, Narayan S, Rabidas V, Pandey K, Kumar A, Das P and Bimal S. Immunomodulation in Human Dendritic Cells Leads to Induction of Interferon-Gamma Production by Leishmania donovani Derived KMP-11 Antigen via Activation of NF-κB in Indian Kala-Azar Patients. Biomed Res Int. 2014; 2014: 947606. doi: 10.1155/2014/947606.

57.

Kumar V, Bimal S, Singh SK, Chaudhary R, Das S, Lal C, Pandey K, Das VR and Das P. Leishmania donovani: Dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis. Nutrition. 2014; 30(4): 449-458.

56.

Pandey K, Singh D, Das VR, Bimal S, Singh BK and Das P. Progressive Multifocal Leukoencephalopathy Associated with Pulmonary Tuberculosis in an Immuno-Compromised Indian Patient. J AIDS Clin Res. 2013; 4: 9. http://dx.doi.org/10.4172/2155-6113.1000241.

 

55.

Shivam P, Jamal F, Kumari S, Bimal S, Narayan S, Das VN, Pandey K, Gupta AK, Singh D, Verma N, Das P and Singh SK. Leishmania donovani: Influence of anti-leishmanial therapy on expression of lymphocyte function-associated antigen-3 and its relevance to pathogenisis in visceral leishmaniasis. Hum Immunol. 2013; 74(12): 1575-1578. doi: 10.1016/j.humimm.2013.08.007. (Epub 2013 Aug 20).

54.

Guha R, Gupta D, Rastogi R, Vikram R, Krishnamurthy G, Bimal S, Roy S and Mukhopadhyay A. Vaccination with leishmania hemoglobin receptor-encoding DNA protects against visceral leishmaniasis. Sci Transl Med. 2013; 5(202): 202ra121. doi: 10.1126/scitranslmed.3006406.

53.

Thakur AK, Bimal S, Singh SK, Gupta AK, Das VN, Das P and Narayan S. Degree of anemia correlates with increased utilization of heme by Leishmania donovani parasites in visceral leishmaniasis. Exp Parasitol. 2013; 135(3): 595-598. doi: 10.1016/j.exppara.2013.09.008.

52.

Bimal S, Sinha S, Singh SK, Narayan S, Kumar V, Verma N, Ranjan A, Sinha PK, Das VN, Pandey K, Kar SK and Das P. Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection. Exp Parasitol. 2012; 131(3): 274-282. (Epub 2012 May 10).

51.

 

Pandey K, Das VN, Singh D, Das S, Lal CS, Verma N, Bimal S, Topno RK, Siddiqui NA, Verma RB, Sinha PK and Das P. Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India. J Clin Microbiol. 2012; 50(4): 1478-1479. (Epub 2012 Jan 25).

50.

Singh SK, Bimal S, Narayan S, Jee C, Bimal D, Das P and Bimal R. Leishmania donovani: assessment of leishmanicidal effects of herbal extracts obtained from plants in the visceral leishmaniasis endemic area of Bihar, India. Exp Parasitol, 2011; 127(2): 552-558. (Epub 2010 Nov 9).

49. 

Das VNR, Pandey K, Verma N, Bimal S, Lal CS, Singh D and Das P. Post-kala-azar dermal leishmaniasis(PKDL), HIV and pulmonary tuberculosis . National Medical Journal of India. 2010; 23(2): 88-89.

48. 

Topno RK, Das VN, Ranjan A, Pandey K, Singh D, Kumar N, Siddiqui NA, Singh VP, Kesari S, Kumar N, Bimal S, Kumar AJ, Meena C, Kumar R and Das P. Asymptomatic infection with visceral leishmaniasis in a disease-endemic area in bihar, India. Am J Trop Med Hyg, 2010; 83(3): 502-506.

47. 

Das VN, Pandey K, Verma N, Lal CS, Bimal S, Topno RK, Singh D, Siddiqui NA, Verma RB and Das P. Development of Post Kala-Azar Dermal Leishmaniasis (PKDL) in Miltefosinetreated visceral leishmaniasis. American Journal of Tropical Medicine and Hygiene, 2009; 80(3): 336-338.


46. 

Narayan S, Bimal S, Singh SK, Gupta AK, Singh VP, Sinha PK and Das P. Leishmania donovani vs Immunity: T-cells sensitized from Leishmaniaof one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis. Experimental Parasitology, 2009; 121: 69-75.


45. 

Pandey K, Sinha PK, Das VN, Bimal S, Singh SK and Das P. Pharmacotherapeutic Options for Visceral Leishmaniasis—Current Scenario. Clinical Medicine: Pathology, 2009; 2: 1–4.

 

44. 

Pandey k, Sinha PK, Das VN, Nawin Kumar, Bimal S, Verma RB, Verma N, Lal CS, Topno RK, Siddiqui NA, Singh D and Das P. Tuberous sclerosis with visceral leishmaniasis: a case report. Journal of Medical Case Reports, 2009; 3: 9027.


43. 

Bimal S, Singh SK, Sinha S, Pandey K, Sinha PK, Ranjan A, Bhattacharya SK and Das P. Leishmania donovani: Role of CD2 on CD4+ T – cell function in Visceral leishmaniasis. Exp. Parasitol, 2008; 118(2): 238-246.

42. 

Sinha PK, Bimal S, Pandey K, Singh SK, Ranjan A, Kumar N, Lal CS, Barman SB, Verma RB, Jeyakumar A, Das P, Bhattacharya M, Sur D and Bhattacharya SK. A community-based, comparative evaluation of direct agglutination and rK39 strip tests in the early detection of subclinical Leishmania donovani infection. Ann. Trop. Med. & Parasitol, (2008); 102(2): 119-125.

41

Kumar N, Pandey K, Das VN, Sinha PK, Topno RK, Lal CS, Bimal S, Verma N and Das P. HIV infection, visceral leishmaniasis and Guillain –Barre syndrome in same patient: a case report. Ann. Trop. Med. & Parasitol, 2008; 102(2): 185-188.

40. 

Mookerjee Basu J, Mookerjee A, Banerjee R, Saha M, Singh S, Naskar K, Tripathy G, Sinha PK, Pandey K, Sundar S, Bimal S, Pradeep Das, Choudhuri SK and Roy S. Inhibition of ABC Transporters Abolishes Antimony Resistance in Leishmania Infection. Antimicrob Agents Chemother, 2008; 52(3): 1080-1093.


39. 

Topno RK, Pandey K, Das VN, Kumar N, Bimal S, Verma RB, Siddiqui NA, Singh D, Kumar R, Kumar P, Ranjan A, Das P and Sinha PK. Visceral Leishmaniasis in pregnancy – role of Amphotericin B. Ann. Trop. Med. & Parasitol, 2008; 102(3): 267-270.

38. 

Pandey K, Sinha PK, Rabidas V, Kumar N, Bimal S, Verma N, Lal C and Das P. HIV, visceral leishmaniasis and Parkinsonism combined with diabetes mellitus and hyperuricaemia: A case report. Cases Journal, 2008; 1: 183.


37. 

Sundar S, Singh RK, Bimal SK, Gidwani K, Mishra A, Maurya R, Singh SK, Manandhar KD, Boelaert M and Rai M. Comparative evaluation of parasitology and serological tests in the diagnosis of visceral leishmaniasis in India: a phase III diagnostic accuracy study. Tropical Medicine and International Health, 2007; 12(2): 284-289.


36. 

Lal CS, Kumar A, Kumar S, Pandey K, Kumar N, Bimal S, Sinha PK and Das P. Hypocholesterolemia and increased triglycerides in paediatric visceral leishmaniasis. Clinica Chimica Acta, 2007; 382(1-2): 151-153.


35. 

Pandey K, Sinha PK, Das VN, Kumar N, Verma N, Bimal S, Lal CS, Topno RK, Singh D, Verma RB, Bhattacharya SK and Das P. Wilson Disease with Visceral Leishmaniasis: An Extremely Uncommon Presentation. Am J Trop Med Hyg, 2007; 77(3): 560 – 561.

34. 

Sinha PK, Bimal S, Singh SK, Pandey K, Gangopadhyay DN, And Bhattacharya SK. Pre and Post Treatment evaluation of Immunological features in Indian Visceral Leishmaniasis patient with HIV Co-Infection. Indian J Med Res, 2006; 123: 197-202.


33. 

Das VN, Pandey K, Kumar N, Hassan SM, Bimal S, Lal CS, Siddiqui NA and Bhattacharya SK. Visceral leishmaniasis and tuberculosis in patients with HIV co-infection. Southeast Asian J Trop Med Public Health, 2006; 37(1): 18-21.


32. 

Pranati, Bimal S, Pandey K, Sinha PK, Gupta AK, Singh SK, Sundaram S and Das P. Leishmania donovani: Immunomodulatory Role of 63KDa Leishmania Antigen in the Promotion of IFN-gamma Response (VL vs HIV-VL Co-infection). American Journal of Immunology, 2006; 2(2): 52-57.

 

31. 

Kumar V, Bimal S, Kesari S, Kumar AJ, Bagchi AK, Akbar MA, Kishore K, Bhattacharya SK and Das P. Evaluation of a dot-imunoblot assay for detecting leishmanial antigen in naturally infected Phlebotomus argentipes (Diptera: sychodidae). Ann Trop Med Parasitol. 2005; 99(4): 371-376.

30. 

Das VN, Ranjan A, Bimal S, Siddique NA, Pandey K, Kumar N, Verma N, Singh VP, Sinha PK and Bhattacharya SK. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar. Natl Med J India, 2005; 18(3): 131-133.


29. 

Bimal S, Das VN, Sinha PK, Gupta AK, Verma N, Ranjan A, Singh SK, Sen A, Bhattacharya SK and Das P. Usefulness of the direct agglutination test in the early detection of subclinical L.  donovani infection: a community-based study. Ann Trop Med Parasitol, 2005; 99: 743-749.

28. 

Bimal S, Singh SK, Das VN, Sinha PK, Gupta AK, Bhattacharya SK and Das P. Leishmania donovani: effect of therapy on expression of CD2 antigen and secretion of macrophage migration inhibition factor by T-cells in patients with visceral leishmaniasis. Exp Parasitol. 2005; 111(2): 130-132.

27. 

Pandey K, Sinha PK, Das VN, Kumar N, Hassan SM, Verma N, Lal CS, Bimal S, Das P and Bhattacharya SK. HIV-I infection, visceral leishmaniasis, Koch's chest and tuberculous meningitis in the same patient- a case report. Ann Trop Med Parasitol, 2005; 99(8): 807-811.

26. 

Bimal S,  Singh S, Pandey K, Sinha PK, Das PK, Schallig H, Das P and Bhattacharya SK. Comparative evaluation of aqueous and freeze dried antigen for Sero-diagnosis of VL and PKDL cases by DAT. American Journal of Immunology, 2005; 1(2): 74-78.

 

25. 

Singh SK, Bimal S, Dinesh DS, Gupta AK, Sinha PK, Bimal R and Das P. Towards identifying immunogenic targets in visceral leishmaniasis: role of 17 kDa and 63 kDa phosphoproteins. American Journal of Infectious Diseases, 2005; 1 (3): 94-98.

 

24. 

Singh SK, Bimal S, Dinesh DS, Gupta AK, Sinha PK, Bimal R and Das P. Towards Identifying Immunogenic Targets in Visceral Leishmaniasis: Role of 17kDa and 63kDa Phosphoproteins. American Journal of Immunology, 2005; 1(3): 96-100.

 

23. 

Bimal S, Das VNR, Sinha PK, Gupta AK, Verma N, Ranjan A, Singh SK, Bhattacharya SK and Pas P. Relevance of direct agglutination test for detection of sub-clinical infection among contacts of kala-azar and non- kala-azar households. J Immunol Immunopathol. 2004; 6(S-1): 85.      

 

22. 

Dasgupta B, Roychoudhury K, Ganguly S, Kumar Sinha P, Vimal S, Das P and Roy S.Antileishmanial drugs cause up-regulation of interferon-gamma receptor 1, not only in the monocytes of visceral leishmaniasis cases but also in cultured THP1 cells. Ann Trop Med Parasitol. 2003; 97(3): 245-257.

21. 

Verma N, Bimal S, Gupta AK, Das VNR, Kar SK and Bhattacharya SK. Imunohistochemical staining of dermal lesions in diagnosis of Post Kala-azar Dermal leishmaniasis (PKDL) in compare to Biopsy Imprint Smear & Culture. Jour of Lab Med, 2002; 3(1): 41-42.

 

20. 

Bimal S, Bagchi AK, Das V, Sinha PK, Lal CS, Ranjan A, Gupta AK and Kar SK. Effect of immunization with lipid associated polysaccharide antigen and anti CD-2 antibodies on class II MHC expression and cellular immune response in BALB/C mice infected with leishmania donovani. Indian Journal of Experimental Biology, 2001; 39: 878-882.

19. 

Sharma MC, Bimal S, Ranjan A, Das VN, Gupta AK, Kumar N and Kar SK. Relevance of direct agglutination test in sero-epidemiological survey of kala-azar in epidemic foci of Bihar. Journal of Communicable Diseases, 2000; 32(2): 117-122.

18. 

Ranjan A, Kumar N, Das VNR, Palit A, Kishore K, Bimal S, Siddique NA, Singh VP and Kar SK. Epidemiological Parameters in Epidemic and Endemic areas of Visceral Leishmaniasis in Bihar, India. Journal of Parasitic Diseases, 2000: 24(2): 223-225.

17. 

Singh R, Vimal S, Gupta AK, Sharma MC and Kar SK. Sequential CMI studies in relation to antigen reactive T-cells in cured and drug resistant Kala-azar Cases. Journal of Allergy and Applied Immunology, 1998; 12(2): 87-91.

16. 

Verma N, Bimal S and Kar SK. Histopathological changes of dermal lesion in PKDL in relation to immune response. Indian Journal of Pathology and Microbiology, 1996; 39(1): 52.

 

15. 

Lal S, Bimal S and Lal AH. Anaemia in kala-azar--a preliminary report. J Assoc Physicians India, 1994; 42(2): 171.

14

Kumar V, Bimal S, Kishore K, Palit A. and Saran R. Studies on vector-host relationship in Visceral Leishmaniasis: An Immunological Profile. Indian Journal of Parasitology, 1993; 17(1): 27-28.

 

13. 

Bimal S, Lal SL, Lal CS, Singha UK, Saran R, Sen AB and Sahay VK. Reversal of T-cell unresponsiveness through serine-esterase inhibitors mediated enhanced lymphokine induced microbicidal activities in kala-azar. Indian Journal of Exp. Biology, 1992; 30: 54-56.

12. 

Bimal S, Lal SL, Lal CS, Singha UK, Saran R, Sen AB and Sahay VK. Reversal of T-cell unresponsiveness through serine-esterase inhibitors mediated enhanced lymphokine induced microbicidal activities in kala-azar. Indian Journal of Exp. Biology, 1992; 30: 54-56.

11. 

Lal S, Bimal S, Gupta AK, Sinha SP, Singha UK and Saran R. Serological survey of visceral leishmaniasis in an endemic village of Bihar. Indian Journal of Comparative Microbiology, Immunology and Infectious Diseases, 1992; 13(1 &2): 28-30.

10.

 

Lal S, Lal CS, Sinha SP, Bimal S, Lal AHB and Saran R.  Study of acid phosphatase to assess host parasite relationship in visceral leishmaniasis. Indian Journal of Comparative Microbiology, Immunology and Infectious Diseases, 1992; 13(3&4): 94-99.

9. 

Lal S, Bimal S, Gupta AK, Sinha SP, Singha UK and Saran R. Serological survey of visceral leishmaniasis in an endemic village of Bihar. Indian Journal of Comparative Microbiology, Immunology and Infectious Diseases, 1992; 13(1 &2): 28-30.

8.

Lal S, Lal CS, Sinha SP, Bimal S, Lal AHB and Saran R.  Study of acid phosphatase to assess host parasite relationship in visceral leishmaniasis. Indian Journal of Comparative Microbiology, Immunology and Infectious Diseases, 1992; 13(3&4): 94-99.

7.

Lal SL, Bimal S and Prasad LSN. Detection and analysis of circulating immune complexes and their influence on cell mediated immune reactions in Visceral Leishmaniasis. Indian Journal of Parasitology, 1992; 16(1): 27-29.

 

6.

Lal SL, Bimal S and Prasad LSN. Detection and analysis of circulating immune complexes and their influence on cell mediated immune reactions in Visceral Leishmaniasis. Indian Journal of Parasitology, 1992; 16(1): 27-29.

 

5.

Lal S, Bimal S, Sinha AN and Prasad LS. Role of HLA-DR antigen on T-cell activation in Visceral Leishmaniasis. Indian Journal of Experimental Biology, 1991; 29: 1101-1103. 

4.

Bimal S, Lal SL, Lal CS, Singha UK, Sen AB and Sahay VK. Enhancement of MIF activity of T-cell mitogen to assess its role in provocating acid phosphatase relaease from macrophage in visceral leishmaniasis. Indian Journal of Parasitology, 1991; 15(1). 153.

 

3.

Bimal S, Lal SL, Lal CS, Verma N and Sinha AN. Study of Host Immune System during course of L.donovani infection. Indian Journal of Parasitology, 1991; 15(1): 53-56.

 

2.

Bimal S, Lal SL, Lal CS and Sinha AN. Analysis of different macrophage population to study role of macrophage in generation of specific immune protection in Visceral Leishmaniasis. Indian journal of Parasitology, 1990; 14(2): 191-195.

 

1.

Kumar V, Roy MS, Sinha N K, Prasad M, Bimal S and Kishore K. Study of host preference of Phlebotomus argentipes of Patna district, Bihar. MENDAL, 1990; 7(3-4): 399-401.